Australia markets close in 6 minutes

Sorrento Therapeutics, Inc. (SRNE)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
4.2300-0.3300 (-7.24%)
At close: 04:00PM EST
4.2400 +0.01 (+0.24%)
After hours: 07:57PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 1.90B
Enterprise value 1.94B
Trailing P/E N/A
Forward P/E 4.00
PEG ratio (5-yr expected) N/A
Price/sales (ttm)34.37
Price/book (mrq)14.44
Enterprise value/revenue 37.78
Enterprise value/EBITDA -5.77

Trading information

Stock price history

Beta (5Y monthly) 2.17
52-week change 3-54.54%
S&P500 52-week change 321.05%
52-week high 317.2500
52-week low 34.2200
50-day moving average 35.6486
200-day moving average 37.3978

Share statistics

Avg vol (3-month) 35.53M
Avg vol (10-day) 34.77M
Shares outstanding 5306.34M
Implied shares outstanding 6N/A
Float 8276.44M
% held by insiders 16.35%
% held by institutions 124.45%
Shares short (30 Dec 2021) 442.89M
Short ratio (30 Dec 2021) 46.43
Short % of float (30 Dec 2021) 414.22%
Short % of shares outstanding (30 Dec 2021) 414.00%
Shares short (prior month 29 Nov 2021) 445.36M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:25
Last split date 331 July 2013

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Sept 2021


Profit margin 0.00%
Operating margin (ttm)-643.89%

Management effectiveness

Return on assets (ttm)-30.49%
Return on equity (ttm)-258.42%

Income statement

Revenue (ttm)51.33M
Revenue per share (ttm)0.18
Quarterly revenue growth (yoy)2.60%
Gross profit (ttm)-81.29M
EBITDA -318.71M
Net income avi to common (ttm)-355.41M
Diluted EPS (ttm)-1.2490
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)162.67M
Total cash per share (mrq)0.54
Total debt (mrq)202.56M
Total debt/equity (mrq)154.24
Current ratio (mrq)1.15
Book value per share (mrq)0.44

Cash flow statement

Operating cash flow (ttm)-250.55M
Levered free cash flow (ttm)-109.08M